What test checks if a patient is ready for extubation (removal of endotracheal tube)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Extubation Readiness Testing

A spontaneous breathing trial (SBT) is the primary test to check if a patient is ready for extubation, and should be performed as part of a protocolized extubation readiness testing (ERT) bundle that includes assessment of airway patency, cough effectiveness, secretion management, and neurologic control. 1

Core Components of Extubation Readiness Assessment

1. Protocolized Screening

  • Daily screening should be performed for all patients mechanically ventilated >24 hours to identify eligibility for extubation readiness testing 1, 2
  • Screening assesses resolution of the primary indication for mechanical ventilation, adequate oxygenation (FiO₂ ≤0.5, PEEP ≤6 cm H₂O, SpO₂ >92%), hemodynamic stability, and adequate respiratory drive 1, 3

2. Spontaneous Breathing Trial (SBT) - The Gold Standard Test

The SBT objectively assesses the patient's ability to independently maintain adequate minute ventilation and gas exchange without excessive respiratory effort 1, 4

SBT Technique Selection:

  • For standard-risk patients: Use pressure support ventilation of 5-8 cm H₂O with CPAP for 30 minutes 1, 4, 2

    • This approach achieves higher success rates (84.6% vs 76.7% with T-piece) and better extubation outcomes (75.4% vs 68.9%) 4, 2, 5
  • For high-risk patients: Use CPAP alone (without pressure support) for 60-120 minutes to better assess true extubation readiness 1, 4

    • High-risk features include: prolonged ventilation >14 days, chronic lung disease, myocardial dysfunction, neurologic impairment, upper airway anomalies, or previously failed extubation 4, 3

SBT Failure Criteria (Monitor During Trial):

  • Respiratory rate >30/min or <10/min 4, 3
  • Oxygen desaturation (SpO₂ <92%) 4, 3
  • Respiratory distress (accessory muscle use, paradoxical breathing, diaphoresis) 4, 3
  • Hemodynamic instability (tachycardia, hypertension, hypotension) 4, 3
  • Altered mental status or agitation 4, 3

3. Additional Critical Assessments Beyond SBT

Cuff Leak Test (Airway Patency Assessment):

  • Perform before extubation to predict laryngeal edema risk, especially in patients with risk factors: female gender, traumatic/difficult intubation, large tube size, prolonged intubation 3
  • Deflate the endotracheal tube cuff and measure the difference between inspired and expired tidal volumes 3
  • If leak volume is low or absent, administer corticosteroids at least 6 hours before extubation 1, 3
  • In pediatric patients with cuffed ETT, air leak pressure >25 cm H₂O indicates high risk for postextubation upper airway obstruction 3

Respiratory Muscle Strength Assessment:

  • Measure PiMax (maximal inspiratory pressure) as an element of the ERT bundle for critically ill children at risk for muscle weakness or extubation failure 1
  • Airway occlusion pressure (P0.1) ≤4 cm H₂O indicates likely extubation success, while >6 cm H₂O predicts weaning failure 3

Cough Effectiveness and Secretion Management:

  • Assess cough strength and sputum load before extubation 4, 3
  • Evaluate bulbar function to ensure adequate airway protection 4, 3

Algorithmic Approach to Extubation Decision

  1. Daily screening: Check if patient meets basic criteria (adequate oxygenation, hemodynamic stability, resolution of primary indication) 1, 2

  2. Perform SBT:

    • Standard-risk: 30 minutes with PS 5-8 cm H₂O 4, 2
    • High-risk: 60-120 minutes with CPAP alone 1, 4
  3. If SBT successful, assess:

    • Cuff leak test (especially if risk factors present) 3
    • Cough effectiveness 4, 3
    • Secretion burden 4, 3
    • Neurologic status/airway protection 1, 3
  4. If all assessments favorable: Proceed with extubation 1, 2

  5. Post-extubation support:

    • For high-risk patients (reintubation risk >20%), apply prophylactic NIV immediately after extubation 2
    • For children <1 year at high risk, use CPAP over high-flow nasal cannula 2

Critical Pitfalls to Avoid

  • Do not perform repeat SBTs on the same day after failure - this can lead to respiratory muscle fatigue and worsening respiratory mechanics 4
  • Do not rely solely on successful SBT - approximately 10% of patients who pass an SBT will still fail extubation due to issues with airway patency, secretions, or cough 4, 3
  • Do not skip cuff leak testing in high-risk patients - absence of a leak around an appropriately sized tube generally precludes safe extubation 3
  • Avoid using T-piece alone for initial SBT in standard-risk patients - pressure support trials are more likely to result in successful extubation without increasing reintubation rates 4, 5, 6

Pediatric-Specific Considerations

  • Use protocolized ERT bundles including SBT assessment 1, 2
  • Administer dexamethasone at least 6 hours before extubation in children at high risk of postextubation upper airway obstruction 1, 2, 3
  • For children at higher risk of extubation failure, use CPAP without pressure support during SBTs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Extubation in Ventilated Patients: Evidence-Based Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Extubation Readiness Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

T-Piece Spontaneous Breathing Trial Duration and Criteria for Extubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.